Cargando…
GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis
Herein, we elucidated the molecular mechanisms and therapeutic potential of glutathione peroxidase 2 (GPX2) in bladder cancer. GPX2 expression gradually increased during progression from normal to papillary or nodular hyperplasia (PNHP) and urothelial carcinoma (UC) in a rat N-butyl-N-(4-hydroxybuty...
Autores principales: | Naiki, Taku, Naiki-Ito, Aya, Iida, Keitaro, Etani, Toshiki, Kato, Hiroyuki, Suzuki, Shugo, Yamashita, Yoriko, Kawai, Noriyasu, Yasui, Takahiro, Takahashi, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882302/ https://www.ncbi.nlm.nih.gov/pubmed/29662611 http://dx.doi.org/10.18632/oncotarget.24627 |
Ejemplares similares
-
Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
por: Iida, Keitaro, et al.
Publicado: (2020) -
NCL1, A Highly Selective Lysine-Specific Demethylase 1 Inhibitor, Suppresses Castration-Resistant Prostate Cancer Growth via Regulation of Apoptosis and Autophagy
por: Etani, Toshiki, et al.
Publicado: (2019) -
Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer
por: Naiki-Ito, Aya, et al.
Publicado: (2020) -
A Case of Renal Primitive Neuroectodermal Tumor Confirmed by Fluorescence in situ Hybridization
por: Etani, Toshiki, et al.
Publicado: (2015) -
Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report
por: Etani, Toshiki, et al.
Publicado: (2016)